Skip to main content
. 2022 May 14;77(3):438–443. doi: 10.1007/s12020-022-03075-y

Fig. 1.

Fig. 1

Patients with poor performance status before A and after (B) chemotherapy (3 cycles) preceded by a single administration of cisplatin (45 mg/m2) in a 24-hour continuous infusion